CAMP vs KEYS · rev $652.0K vs P/E 57, rev $4.98B
CAMP4 THERAPEUTICS CORPORATION (CAMP) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported CAMP revenue for 2024-12-31 was $652.0K. Net income was -$51.8M. Revenue was up 86.3% from 2023-12-31 to 2024-12-31. CAMP currently screens at market cap $215.0M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
CAMP currently screens at market cap $215.0M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the CAMP and KEYS stock pages for the full models.
Not investment advice.